Most linked-to pages
From GxPlex
Showing below up to 50 results in range #751 to #800.
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 10. (6 links)
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 6. (6 links)
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 4 (6 links)
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 3 Part 1 1. ; 3. (6 links)
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 7 Part 2 2. (6 links)
- Reference:ICH ICH E19 Guideline 2022 6 (6 links)
- Reference:ICH ICH E21 Concept paper 2023 2. (6 links)
- Reference:ICH ICH E2A Guideline 1994 III A. 2. (6 links)
- Reference:ICH ICH E2A Guideline 1994 III E (6 links)
- Reference:ICH ICH E2A Guideline 1994 II A. 3. (6 links)
- Reference:ICH ICH E2A Guideline 1994 II B. Serious/Severe (6 links)
- Reference:ICH ICH E2A Guideline 1994 II B. Serious Adverse Event or Adverse Drug Reaction (6 links)
- Reference:ICH ICH E2F Guideline 2010 1 (6 links)
- Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 2.3 (6 links)
- Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 2.3.2 (6 links)
- Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 2.4 - 2.5 (6 links)
- Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 3 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix A 3.4 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 14.3 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 2.5 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 8 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 9.4 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix C-001 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix C-002 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix C C.2.3 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Adverse Drug Reaction (ADR) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Agreement (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Case Report Form (CRF) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Certified Copy (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Comparator (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Compliance (in relation to trials) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Data Acquisition Tool (DAT) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Independent Data Monitoring Committee (IDMC) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Informed Consent (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Institutional Review Board (IRB)/Independent Ethics Committee (IEC) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Service Provider (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 1.2.7 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.12.1 - 2.12.3 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.2 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.3 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.6 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.7.1-001 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.7.2 (a) (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.12 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.8 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.9 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.1 (6 links)
- Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.3 (6 links)